The prevalence of antibodies (IgG) to Toxoplasma gondii among 180 adults from the Nigerian city of Maiduguri was determined as 23.9%, using a commercial ELISA. Although the men investigated were more likely to be seropositive than the women, the difference was not statistically significant (27.3% v. 19.8%; P>0.05). There was also no apparent association between educational level and seroprevalence. There was a positive correlation between the mean antibody titre and the age of the subjects, with seroprevalence highest among the subjects aged 51-60 years and lowest in the subjects aged<21 years. Worryingly, 10 (20%) of the 50 female subjects who were of child-bearing age (15-40 years) were among those found seropositive for anti-T. gondii IgG. The mean antibody titres of the seropositive subjects ranged between 16.5 IU/ml (the threshold for positivity being 16 IU/ml) and >1000 IU/ml. In addition to age, occupation and eating habits were also significantly associated with seropositivity. Compared with the subjects who had no pets, dog owners were twice as likely to be seropositive. The relative risks for cat and dog ownership were, however, only 0.79 and 0.69, respectively, indicating that these animals might not be the main sources of human infection with T. gondii in the study area.
Serum samples were collected from 372 sheep and same number of goats from the three geopolitical zones of Borno state, Nigeria. The samples were tested for the presences of Toxoplasma gondii antibodies by enzyme-linked immunosorbent assay. Of these, 6.7% (25/372) and 4.6% (17/372) of sheep and goats, respectively, were found to be seropositive to T. gondii antibodies, both far less than the estimated global average of 31%. Results were statistically analyzed by chi-square (chi(2)) test. The results showed that age, environmental conditions, and farm location are the main determinants of prevalence of antibodies against T. gondii in the study area. Older animals (>3 years) are significantly more infected than younger animals (between 6 months and 1 year).The prevalence of anti T. gondii antibodies is significantly higher (P < 0.05) in both sheep and goats sampled from the southern zone than the northern zone. Animals from the southern zones are about four times more likely to be exposed to T. gondii infection than those in the northern zone, (sheep; odds ratio (OR) = 4.25, 95% confidence interval (CI) = 1.177-15.36, P = 0.018), (goats; OR = 4.38, 95% CI = 0.925-20.73, P = 0.04). Farm location in urban area was identified as a risk factor for sheep (OR = 6.06, 95% CI = 2.53-14.54, P = 0.000), and goats (OR = 4.99, 95% CI = 1.59-15.62, P = 0.004). Current data on prevalence of ovine and caprine T. gondii in Borno state are provided by the study as well as identifying the main risk factors associated with T. gondii infection in the area.
The seroprevalence of Toxoplasma gondii (T. gondii) antibodies in dogs in Maiduguri, the capital of Borno State, Nigeria, was determined using the Latex Aagglutination Test (LAT). Antibodies (LAT titer > 1:64) to T. gondii were found in 42 (25%) of the animals examined. Antibody titers in positive dogs ranged from 1:64 (15 dogs) to1:2048 (3 dogs). There was a significant statistical difference (P < 0.05) between age groups of dogs, the prevalence being higher in dogs ≥ 3 years (Χ2 = 13.73 P = 0.0002, OR 2.80 CI95% 1.28-6.13 P = 0.008). Pure Alsatians and their crosses were less likely to be seropositive (OR cross breed 0.28 CI95% 0.13-0.61 P = 0.001, OR Alsatian 0.16 CI95% 0.04-0.58 P = 0.002). The high prevalence of T. gondii infection that we found in dogs suggests a need for a larger survey to determine the national prevalence and identify possible risk factors in different agro-climatic zones. Such a study will help in formulating nation-wide control measures for toxoplasmosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.